BDSI: Collegium Pharmaceutical's Acquisition of BioDelivery Sciences International
Goodwin Procter advised BioDelivery Sciences International on the deal. BioDelivery Sciences International (NASDAQ: BDSI) announced its definitive merger agreement to be acquired by Collegium Pharmaceutical (Nasdaq: COLL). [...]
Read full article »
BDSI is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies for the treatment of debilitating chronic conditions.
Read more